Cargando…
The Protective Role of Adiponectin for Lipoproteins in End-Stage Renal Disease Patients: Relationship with Diabetes and Body Mass Index
Cardiovascular disease (CVD) events are the main causes of death in end-stage renal disease (ESRD) patients on dialysis. The number and severity of CVD events remain inappropriate and difficult to explain by considering only the classic CVD risk factors. Our aim was to clarify the changes and the re...
Autores principales: | Coimbra, Susana, Reis, Flávio, Nunes, Sara, Viana, Sofia, Valente, Maria João, Rocha, Susana, Catarino, Cristina, Rocha-Pereira, Petronila, Bronze-da-Rocha, Elsa, Sameiro-Faria, Maria, Oliveira, José Gerardo, Madureira, José, Fernandes, João Carlos, Miranda, Vasco, Belo, Luís, Santos-Silva, Alice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397972/ https://www.ncbi.nlm.nih.gov/pubmed/30911344 http://dx.doi.org/10.1155/2019/3021785 |
Ejemplares similares
-
Subpopulations of High-Density Lipoprotein: Friends or Foes in Cardiovascular Disease Risk in Chronic Kidney Disease?
por: Coimbra, Susana, et al.
Publicado: (2021) -
Hepcidin and diabetes are independently related with soluble transferrin receptor levels in chronic dialysis patients
por: Belo, Luís, et al.
Publicado: (2019) -
Long Pentraxin 3 as a Broader Biomarker for Multiple Risk Factors in End-Stage Renal Disease: Association with All-Cause Mortality
por: Valente, Maria João, et al.
Publicado: (2019) -
Interleukin 6 (rs1800795) and pentraxin 3 (rs2305619) polymorphisms-association with inflammation and all-cause mortality in end-stage-renal disease patients on dialysis
por: Rocha, Susana, et al.
Publicado: (2021) -
Cell-free DNA as a marker for the outcome of end-stage renal disease patients on haemodialysis
por: Coimbra, Susana, et al.
Publicado: (2020)